Abiko, Japan

Hideaki Matsuda



Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 130(Granted Patents)


Company Filing History:


Years Active: 1986-2001

Loading Chart...
Loading Chart...
29 patents (USPTO):Explore Patents

Title: **Innovations and Contributions of Hideaki Matsuda**

Introduction

Hideaki Matsuda, based in Abiko, Japan, is an accomplished inventor with a notable portfolio of 29 patents. His work primarily focuses on pharmaceutical innovations, particularly in treatments addressing urinary disturbances and diabetic complications.

Latest Patents

One of Matsuda's latest patents is a substituted piperidine derivative aimed at treating urinary disturbances. This invention is represented by a specific general formula and offers potential therapeutic benefits. Another significant contribution is related to chromene derivatives and their salts, disclosed in a recent patent. These derivatives exhibit exceptional inhibitor action against advanced glycation end-products (AGE) formation, making them valuable in preventing and treating complications associated with diabetes. The detailed structure of these chromene derivatives further enhances their utility in medical applications.

Career Highlights

Throughout his career, Hideaki Matsuda has made remarkable strides in the pharmaceutical industry. He has worked with reputable companies including Ss Pharmaceutical Co., Ltd. and Ssp Co. Ltd. His dedication to innovation in pharmaceuticals has earned him a respected place among his peers.

Collaborations

Matsuda has collaborated with notable colleagues such as Takemitsu Asaoka and Susumu Sato. These collaborations have fostered an environment of shared knowledge and innovation, leading to the development of beneficial medical solutions.

Conclusion

With a strong focus on innovations in pharmaceuticals, Hideaki Matsuda continues to push the boundaries of medical treatments through his inventions. His contributions significantly impact the field, providing essential solutions for patients and advancing the pharmaceutical industry as a whole.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…